Dr. Christophe Olyslaegers
ActiveSummary
Dr. Christophe Olyslaegers has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €308k and a net result of €149k. Equity is growing by ~14.7% per year across the filed fiscal years. Its solvency ranks better than 34% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
88
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability99▲+5
Solvency75▲+10
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 3.38 against 2.07 in 2023; short-term debt: 13.7% and cash: 15.3% of total assets), and 49.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-08-2025, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
28 d late
2023
1 d early
2022
153 d late
2021
108 d late
2020
153 d late
2019
122 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€308k▲ 1.1%
2023 · €304k
2018: €153k
2019: €153k
2020: €153k
2021: €153k
2022: €269k
2023: €304k
2018 → 2024
Total assets
€613k▼ 19.0%
2023 · €757k
2018: €769k
2019: €874k
2020: €867k
2021: €929k
2022: €904k
2023: €757k
2018 → 2024
Net result
€149k▼ 4.4%
2023 · €155k
2018: €115k
2019: €134k
2020: €102k
2021: €148k
2022: €116k
2023: €155k
2018 → 2024
Working capital
€200k▼ 1.3%
2023 · €203k
2018: €164k
2019: €61k
2020: €79k
2021: €58k
2022: €173k
2023: €203k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€153k-€153k=€269k▲ 75.8%€304k▲ 13.1%€308k▲ 1.1%
Operating result€147k-€208k▲ 41.9%€178k▼ 14.4%€218k▲ 22.3%€218k▲ 0.4%
Net result€102k-€148k▲ 44.2%€116k▼ 21.4%€155k▲ 33.8%€149k▼ 4.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 0% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €613k
Fixed assets
€329k ▼ 9.6%
Current assets
€284k ▼ 27.6%
Equity and liabilities €613k
Equity
€308k ▲ 1.1%
Debt
€306k ▼ 32.4%
Debt's share of the balance-sheet total falls from 59.8% to 49.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€255k▲
2023 · €253k
Cash flow
€185k▼
2023 · €191k
Current ratio
3.38▲
2023 · 2.07
Debt to equity
0.99▼
2023 · 1.49
ROE
48.3%▼
2023 · 51.0%
ROA
24.2%▲
2023 · 20.5%
Interest coverage
24.96▲
2023 · 23.60
Debt ≤ 1 year
€84k▼
2023 · €190k
Debt > 1 year
€219k▼
2023 · €256k
Income taxes
€60k▲
2023 · €52k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 51 lines
Balance sheet
Code20232024
Assets
Total assets20/58€757k€613k▼
Fixed assets21/28€364k€329k▼
Tangible fixed assets22/27€364k€329k▼
Land and buildings22€357k€324k▼
Plant, machinery and equipment23€2k€861▼
Furniture and vehicles24€6k€4k▼
Current assets29/58€393k€284k▼
Amounts receivable within one year40/41€138k€77k▼
Trade receivables40€365€13k▲
Other amounts receivable41€138k€63k▼
Current investments50/53-€100k
Cash at bank and in hand54/58€245k€94k▼
Deferred charges and accrued income490/1€10k€14k▲
Equity and liabilities
Total equity and liabilities10/49€757k€613k▼
Equity10/15€304k€308k▲
Contributions10/11€33k€33k=
Reserves13€271k€274k▲
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€271k€274k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€453k€306k▼
Amounts payable after more than one year17€256k€219k▼
Financial debts170/4€256k€219k▼
Amounts payable within one year42/48€190k€84k▼
Current portion of amounts payable after more than one year42€36k€37k▲
Trade debts44€5k€7k▲
Suppliers440/4€5k€7k▲
Taxes, remuneration and social security45€23k€10k▼
Taxes450/3€23k€10k▼
Remuneration and social security454/9€0-
Other amounts payable47/48€126k€30k▼
Accrued charges and deferred income492/3€7k€2k▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€36k€36k▲
Other operating charges640/8€4k€4k▼
Gross operating margin9900€257k€258k▲
Operating profit (loss)9901€218k€218k▲
Financial income75/76B€0€749▲
Recurring financial income75€0€749▲
Financial charges65/66B€11k€10k▼
Recurring financial charges65€11k€10k▼
Profit (loss) for the period before taxes9903€207k€209k▲
Income taxes67/77€52k€60k▲
Profit (loss) for the period9904€155k€149k▼
Profit (loss) for the period to be appropriated9905€155k€149k▼
Appropriation of the result
Profit (loss) to be appropriated9906€155k€149k▼
Transfer from equity791/2-€115k
Transfer to equity691/2€35k€119k▲
To other reserves6921€35k€119k▲
Profit to be distributed694/7€120k€145k▲
Return on contributions (dividend)694€120k€145k▲
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
2024
30-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2018net €155k ▲33.8%
Net result €155k, the highest in the series.
31-12
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 153 days late
2022
31-12
Financial
Equity above €200kEq €269k ▲75.8%
5 profitable years in a row build equity to €269k.
16-11
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 108 days late
2021
31-12
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 153 days late
2020
31-12
Financial
Weakest financial yearnet €102k ▼23.3%
Net result drops to €102k, the lowest in the series; recovery starts the following year.
30-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 122 days late
2019
02-10
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 63 days late
2018
29-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 29 days late
2017
29-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 29 days late
2016
30-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hove · 1 establishment unit since 2010
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Lintsesteenweg 8082540 HoveGround area
1,553 m²
Building footprint
184 m²
Volume, LiDAR
1,223 m³
Parcel 11021C0100/00M002, Flanders · tallest building 10.9 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Christophe Olyslaegers
since 20102.194.575.807
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11021C0100/00M002 | Flanders | 1,553 m² | 1 · 184 m² | 10.9 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 · 1 entry · 221 EUR awarded · 221 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 221 EUR | 221 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Similar companies · same sector, comparable size
DOKTER K. VALGAEREN
BE 0461.911.030
Mol · Eq €307,597
DR. COUSSENS EMMA, DERMATOLOGIE
BE 0713.775.389
Gent · Eq €307,596
DR. ANN DECLERCQ
BE 0882.393.756
Kapellen · Eq €307,595
Dr. Claire MICHEL
BE 0835.091.707
Florennes · Eq €307,557
DEBRAS MAXILLO
BE 0793.446.241
Namur · Eq €307,542
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,654 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded13-12-2010
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
85599Other education
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.